These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 6571718

  • 1. Effects of alkyl-lysophospholipids on human leukemic cell lines measured by nuclear magnetic resonance.
    Long RC, Small WC, Brynes RK, Tidwell T, Goldstein JH, Vogler WR.
    Cancer Res; 1983 Feb; 43(2):770-5. PubMed ID: 6571718
    [Abstract] [Full Text] [Related]

  • 2. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
    Unger C, Eibl H, Kim DJ, Fleer EA, Kötting J, Bartsch HH, Nagel GA, Pfizenmaier K.
    J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells.
    Berdel WE, Greiner E, Fink U, Stavrou D, Reichert A, Rastetter J, Hoffman DR, Snyder F.
    Cancer Res; 1983 Feb; 43(2):541-5. PubMed ID: 6848177
    [Abstract] [Full Text] [Related]

  • 4. Studies on various parameters influencing leukemic cell destruction by alkyl-lysophospholipids.
    Andreesen R, Modolell M, Oepke GH, Common H, Löhr GW, Munder PG.
    Anticancer Res; 1982 Feb; 2(1-2):95-100. PubMed ID: 7114806
    [Abstract] [Full Text] [Related]

  • 5. The effects of alkyl-lysophospholipids on leukemic cell lines. I. Differential action on two human leukemic cell lines, HL60 and K562.
    Tidwell T, Guzman G, Vogler WR.
    Blood; 1981 Apr; 57(4):794-7. PubMed ID: 6937218
    [Abstract] [Full Text] [Related]

  • 6. Phospholipid-sensitive Ca2+-dependent protein phosphorylation system in various types of leukemic cells from human patients and in human leukemic cell lines HL60 and K562, and its inhibition by alkyl-lysophospholipid.
    Helfman DM, Barnes KC, Kinkade JM, Vogler WR, Shoji M, Kuo JF.
    Cancer Res; 1983 Jun; 43(6):2955-61. PubMed ID: 6850605
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxicity of thioether-lysophospholipids in leukemias and tumors of human origin.
    Berdel WE, Fromm M, Fink U, Pahlke W, Bicker U, Reichert A, Rastetter J.
    Cancer Res; 1983 Nov; 43(11):5538-43. PubMed ID: 6577950
    [Abstract] [Full Text] [Related]

  • 8. Cell-destructive activity in the serum of a tumor patient after infusion of alkyl lysophospholipid.
    Andreesen R, Munder PG.
    J Natl Cancer Inst; 1983 Apr; 70(4):623-7. PubMed ID: 6300501
    [Abstract] [Full Text] [Related]

  • 9. The effect of alkyl-lysophospholipids on tritiated thymidine incorporation and clonogenicity in vitro of normal and leukemic human cells.
    Vogler WR, Whigham EA, Somberg LB, Long RC, Winton EF.
    Exp Hematol; 1984 Aug; 12(7):569-74. PubMed ID: 6540197
    [Abstract] [Full Text] [Related]

  • 10. Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids.
    Dulisch I, Neumann HA, Löhr GW, Andreesen R.
    Blut; 1985 Dec; 51(6):393-9. PubMed ID: 3865693
    [Abstract] [Full Text] [Related]

  • 11. Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines.
    Vogler WR, Whigham E, Bennett WD, Olson AC.
    Exp Hematol; 1985 Aug; 13(7):629-33. PubMed ID: 3861326
    [Abstract] [Full Text] [Related]

  • 12. Purging leukemic cells from simulated human remission marrow with alkyl-lysophospholipid.
    Okamoto S, Olson AC, Vogler WR, Winton EF.
    Blood; 1987 May; 69(5):1381-7. PubMed ID: 3471282
    [Abstract] [Full Text] [Related]

  • 13. Temperature dependence of leukemic cell destruction by alkyl-lysophospholipids (NSC 324368).
    Andreesen R, Modolell M, Oepke GH, Munder PG.
    Exp Hematol; 1983 Jul; 11(6):564-70. PubMed ID: 6617791
    [Abstract] [Full Text] [Related]

  • 14. Changes in cellular lipid synthesis of normal and neoplastic cells during cytolysis induced by alkyl lysophospholipid analogues.
    Herrmann DB.
    J Natl Cancer Inst; 1985 Sep; 75(3):423-30. PubMed ID: 3861897
    [Abstract] [Full Text] [Related]

  • 15. Inhibition by alkyl-lysophospholipids of tritiated thymidine uptake in cells of human malignant urologic tumors.
    Berdel WE, Fink U, Egger B, Reichert A, Munder PG, Rastetter J.
    J Natl Cancer Inst; 1981 May; 66(5):813-7. PubMed ID: 6939927
    [Abstract] [Full Text] [Related]

  • 16. Selective destruction of human leukemic cells by alkyl-lysophospholipids.
    Andreesen R, Modolell M, Weltzien HU, Eibl H, Common HH, Löhr GW, Munder PG.
    Cancer Res; 1978 Nov; 38(11 Pt 1):3894-9. PubMed ID: 279399
    [No Abstract] [Full Text] [Related]

  • 17. Induction of differentiation of cultured human and mouse myeloid leukemia cells by alkyl-lysophospholipids.
    Honma Y, Kasukabe T, Hozumi M, Tsushima S, Nomura H.
    Cancer Res; 1981 Aug; 41(8):3211-6. PubMed ID: 6941852
    [Abstract] [Full Text] [Related]

  • 18. Anti-tumor action of alkyl-lysophospholipids (Review).
    Berdel WE, Bausert WR, Fink U, Rastetter J, Munder PG.
    Anticancer Res; 1981 Aug; 1(6):345-52. PubMed ID: 7046622
    [Abstract] [Full Text] [Related]

  • 19. Quantitative differential effects of rhodamine 123 on normal cells and human colon cancer cells by magnetic resonance spectroscopy.
    Singer S, Neuringer LJ, Thilly WG, Chen LB.
    Cancer Res; 1993 Dec 01; 53(23):5808-14. PubMed ID: 8242640
    [Abstract] [Full Text] [Related]

  • 20. Different modes of internalization of apoptotic alkyl-lysophospholipid and cell-rescuing lysophosphatidylcholine.
    Van Der Luit AH, Budde M, Verheij M, Van Blitterswijk WJ.
    Biochem J; 2003 Sep 15; 374(Pt 3):747-53. PubMed ID: 12837133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.